282 related articles for article (PubMed ID: 2106161)
1. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
Matayoshi ED; Wang GT; Krafft GA; Erickson J
Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
[TBL] [Abstract][Full Text] [Related]
2. A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate.
Holskin BP; Bukhtiyarova M; Dunn BM; Baur P; de Chastonay J; Pennington MW
Anal Biochem; 1995 May; 227(1):148-55. PubMed ID: 7668375
[TBL] [Abstract][Full Text] [Related]
3. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
[TBL] [Abstract][Full Text] [Related]
4. A general method for the preparation of internally quenched fluorogenic protease substrates using solid-phase peptide synthesis.
Maggiora LL; Smith CW; Zhang ZY
J Med Chem; 1992 Oct; 35(21):3727-30. PubMed ID: 1433187
[TBL] [Abstract][Full Text] [Related]
5. Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
Copeland TD; Wondrak EM; Tozser J; Roberts MM; Oroszlan S
Biochem Biophys Res Commun; 1990 May; 169(1):310-4. PubMed ID: 2190554
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases.
Beck ZQ; Lin YC; Elder JH
J Virol; 2001 Oct; 75(19):9458-69. PubMed ID: 11533208
[TBL] [Abstract][Full Text] [Related]
7. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.
Kuo CJ; Chi YH; Hsu JT; Liang PH
Biochem Biophys Res Commun; 2004 Jun; 318(4):862-7. PubMed ID: 15147951
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatographic enzymatic studies with on-line Beta-secretase immobilized enzyme reactor and 4-(4-dimethylaminophenylazo) benzoic acid/5-[(2-aminoethyl) amino] naphthalene-1-sulfonic acid peptide as fluorogenic substrate.
De Simone A; Seidl C; Santos CA; Andrisano V
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():108-14. PubMed ID: 24590190
[TBL] [Abstract][Full Text] [Related]
9. New intramolecularly quenched fluorogenic peptide substrates for the study of the kinetic specificity of papain.
García-Echeverría C; Rich DH
FEBS Lett; 1992 Feb; 297(1-2):100-2. PubMed ID: 1551413
[TBL] [Abstract][Full Text] [Related]
10. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer.
Pennington MW; Thornberry NA
Pept Res; 1994; 7(2):72-6. PubMed ID: 8012123
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates.
Ermolieff J; Loy JA; Koelsch G; Tang J
Biochemistry; 2000 Oct; 39(40):12450-6. PubMed ID: 11015226
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-based continuous assay for the aspartyl protease of human immunodeficiency virus-1.
Geohegan KF; Spencer RW; Danley DE; Contillo LG; Andrews GC
FEBS Lett; 1990 Mar; 262(1):119-22. PubMed ID: 2180743
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.
Shoeman RL; Höner B; Stoller TJ; Kesselmeier C; Miedel MC; Traub P; Graves MC
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6336-40. PubMed ID: 2201025
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.
Cameron CE; Grinde B; Jacques P; Jentoft J; Leis J; Wlodawer A; Weber IT
J Biol Chem; 1993 Jun; 268(16):11711-20. PubMed ID: 8389361
[TBL] [Abstract][Full Text] [Related]
16. Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow CA; Reardon IM; Chaudhary VK; Fryling CM; Pastan I; Fitzgerald DJ
J Virol; 1990 Jul; 64(7):3157-61. PubMed ID: 2161935
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.
Phylip LH; Richards AD; Kay J; Kovalinka J; Strop P; Blaha I; Velek J; Kostka V; Ritchie AJ; Broadhurst AV
Biochem Biophys Res Commun; 1990 Aug; 171(1):439-44. PubMed ID: 2203349
[TBL] [Abstract][Full Text] [Related]
18. A continuous fluorimetric assay for tail-specific protease.
Beebe KD; Pei D
Anal Biochem; 1998 Oct; 263(1):51-6. PubMed ID: 9750142
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of fluorogenic trypsin peptide substrates based on resonance energy transfer.
Grahn S; Ullmann D; Jakubke H
Anal Biochem; 1998 Dec; 265(2):225-31. PubMed ID: 9882396
[TBL] [Abstract][Full Text] [Related]
20. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
